Symbol="BVXV"
AssetType="Common Stock"
Name="BiondVax Pharmaceuticals Ltd ADR"
Description="BiondVax Pharmaceuticals Ltd., a development-stage biopharmaceutical company, focuses on developing, manufacturing and marketing products for the prevention and treatment of infectious and related diseases in Israel. The company is headquartered in Jerusalem, Israel."
CIK="1611747"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="4857100"
EBITDA="-10396000"
PERatio="None"
PEGRatio="0"
BookValue="-1.957"
DividendPerShare="0"
DividendYield="0"
EPS="-2.35"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.309"
ReturnOnEquityTTM="-56.02"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.35"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="39"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="7.48"
EVToRevenue="-"
EVToEBITDA="-2.067"
Beta="2.37"
num_52WeekHigh="11.8"
num_52WeekLow="1.25"
num_50DayMovingAverage="1.373"
num_200DayMovingAverage="2.896"
SharesOutstanding="3651900"
DividendDate="None"
ExDividendDate="None"
symbol="BVXV"
open="1.34"
high="1.36"
low="1.31"
price="1.35"
volume="8519.00"
latest_trading_day="2023-08-31"
previous_close="1.34"
change="0.01"
change_percent="0.7463%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="89"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="11"
Volume_recent_avg="110632"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.82"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="11"
Aroon_momentum_negative="89"
image_negative_thumbnail_id_1="1109"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0142.jpeg"
image_negative_thumbnail_id_2="173"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0003.jpeg"
image_neutral_thumbnail_id_1="586"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_neutral_thumbnail_id_2="528"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_positive_thumbnail_id_1="618"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_positive_thumbnail_id_2="996"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
